全身照射对脐带血造血干细胞移植的影响。

IF 3.4 3区 医学 Q2 HEMATOLOGY
Hao Wang, Kristin N Berger, Elizabeth L Miller, Wei Fu, Larisa Broglie, Frederick D Goldman, Heiko Konig, Su Jin Lim, Arthur S Berg, Julie-An Talano, Melanie A Comito, Sherif S Farag, Jeffrey J Pu
{"title":"全身照射对脐带血造血干细胞移植的影响。","authors":"Hao Wang,&nbsp;Kristin N Berger,&nbsp;Elizabeth L Miller,&nbsp;Wei Fu,&nbsp;Larisa Broglie,&nbsp;Frederick D Goldman,&nbsp;Heiko Konig,&nbsp;Su Jin Lim,&nbsp;Arthur S Berg,&nbsp;Julie-An Talano,&nbsp;Melanie A Comito,&nbsp;Sherif S Farag,&nbsp;Jeffrey J Pu","doi":"10.1177/20406207231170708","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Umbilical cord blood hematopoietic stem cells are commonly used for hematopoietic system reconstitution in recipients after umbilical cord blood transplantation (UCBT). However, the optimal conditioning regimen for UCBT remains a topic of debate. The exact impact of total body irradiation (TBI) as a part of conditioning regimens remains unknown.</p><p><strong>Objectives: </strong>The aim of this study was to evaluate the impacts of TBI on UCBT outcomes.</p><p><strong>Design: </strong>This was a multi-institution retrospective study.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on the outcomes of 136 patients receiving UCBT. Sixty-nine patients received myeloablative conditioning (MAC), in which 33 underwent TBI and 36 did not, and 67 patients received reduced-intensity conditioning (RIC), in which 43 underwent TBI and 24 did not. Univariate and multivariate analyses were conducted to compare the outcomes and the post-transplant complications between patients who did and did not undergo TBI in the MAC subgroup and RIC subgroup, respectively.</p><p><strong>Results: </strong>In the RIC subgroup, patients who underwent TBI had superior overall survival (adjusted hazard ratio [aHR] = 0.25, 95% confidence interval [CI]: 0.09-0.66, p = 0.005) and progression-free survival (aHR = 0.26, 95% CI: 0.10-0.66, p = 0.005). However, in the MAC subgroup, there were no statistically significant differences between those receiving and not receiving TBI.</p><p><strong>Conclusion: </strong>In the setting of RIC in UCBT, TBI utilization can improve overall survival and progression-free survival. However, TBI does not show superiority in the MAC setting.</p>","PeriodicalId":23048,"journal":{"name":"Therapeutic Advances in Hematology","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/03/0e/10.1177_20406207231170708.PMC10161310.pdf","citationCount":"0","resultStr":"{\"title\":\"The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation.\",\"authors\":\"Hao Wang,&nbsp;Kristin N Berger,&nbsp;Elizabeth L Miller,&nbsp;Wei Fu,&nbsp;Larisa Broglie,&nbsp;Frederick D Goldman,&nbsp;Heiko Konig,&nbsp;Su Jin Lim,&nbsp;Arthur S Berg,&nbsp;Julie-An Talano,&nbsp;Melanie A Comito,&nbsp;Sherif S Farag,&nbsp;Jeffrey J Pu\",\"doi\":\"10.1177/20406207231170708\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Umbilical cord blood hematopoietic stem cells are commonly used for hematopoietic system reconstitution in recipients after umbilical cord blood transplantation (UCBT). However, the optimal conditioning regimen for UCBT remains a topic of debate. The exact impact of total body irradiation (TBI) as a part of conditioning regimens remains unknown.</p><p><strong>Objectives: </strong>The aim of this study was to evaluate the impacts of TBI on UCBT outcomes.</p><p><strong>Design: </strong>This was a multi-institution retrospective study.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on the outcomes of 136 patients receiving UCBT. Sixty-nine patients received myeloablative conditioning (MAC), in which 33 underwent TBI and 36 did not, and 67 patients received reduced-intensity conditioning (RIC), in which 43 underwent TBI and 24 did not. Univariate and multivariate analyses were conducted to compare the outcomes and the post-transplant complications between patients who did and did not undergo TBI in the MAC subgroup and RIC subgroup, respectively.</p><p><strong>Results: </strong>In the RIC subgroup, patients who underwent TBI had superior overall survival (adjusted hazard ratio [aHR] = 0.25, 95% confidence interval [CI]: 0.09-0.66, p = 0.005) and progression-free survival (aHR = 0.26, 95% CI: 0.10-0.66, p = 0.005). However, in the MAC subgroup, there were no statistically significant differences between those receiving and not receiving TBI.</p><p><strong>Conclusion: </strong>In the setting of RIC in UCBT, TBI utilization can improve overall survival and progression-free survival. However, TBI does not show superiority in the MAC setting.</p>\",\"PeriodicalId\":23048,\"journal\":{\"name\":\"Therapeutic Advances in Hematology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/03/0e/10.1177_20406207231170708.PMC10161310.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/20406207231170708\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/20406207231170708","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:脐带血造血干细胞常用于脐带血移植(UCBT)后受者的造血系统重建。然而,UCBT的最佳调理方案仍然是一个有争议的话题。作为调理方案的一部分,全身照射(TBI)的确切影响尚不清楚。目的:本研究的目的是评估脑外伤对UCBT结果的影响。设计:这是一项多机构回顾性研究。方法:对136例接受UCBT治疗的患者进行回顾性分析。69例患者接受了清髓调节(MAC),其中33例接受了TBI, 36例未接受TBI; 67例患者接受了降低强度调节(RIC),其中43例接受了TBI, 24例未接受TBI。进行单因素和多因素分析,分别比较MAC亚组和RIC亚组中接受和未接受TBI的患者的结局和移植后并发症。结果:在RIC亚组中,接受TBI的患者总体生存期(校正风险比[aHR] = 0.25, 95%可信区间[CI]: 0.09-0.66, p = 0.005)和无进展生存期(aHR = 0.26, 95% CI: 0.10-0.66, p = 0.005)更优等。然而,在MAC亚组中,接受和未接受TBI的患者之间没有统计学上的显著差异。结论:在UCBT的RIC设置中,TBI的使用可以提高总生存期和无进展生存期。然而,TBI在MAC设置中并没有表现出优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation.

The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation.

The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation.

The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation.

Background: Umbilical cord blood hematopoietic stem cells are commonly used for hematopoietic system reconstitution in recipients after umbilical cord blood transplantation (UCBT). However, the optimal conditioning regimen for UCBT remains a topic of debate. The exact impact of total body irradiation (TBI) as a part of conditioning regimens remains unknown.

Objectives: The aim of this study was to evaluate the impacts of TBI on UCBT outcomes.

Design: This was a multi-institution retrospective study.

Methods: A retrospective analysis was conducted on the outcomes of 136 patients receiving UCBT. Sixty-nine patients received myeloablative conditioning (MAC), in which 33 underwent TBI and 36 did not, and 67 patients received reduced-intensity conditioning (RIC), in which 43 underwent TBI and 24 did not. Univariate and multivariate analyses were conducted to compare the outcomes and the post-transplant complications between patients who did and did not undergo TBI in the MAC subgroup and RIC subgroup, respectively.

Results: In the RIC subgroup, patients who underwent TBI had superior overall survival (adjusted hazard ratio [aHR] = 0.25, 95% confidence interval [CI]: 0.09-0.66, p = 0.005) and progression-free survival (aHR = 0.26, 95% CI: 0.10-0.66, p = 0.005). However, in the MAC subgroup, there were no statistically significant differences between those receiving and not receiving TBI.

Conclusion: In the setting of RIC in UCBT, TBI utilization can improve overall survival and progression-free survival. However, TBI does not show superiority in the MAC setting.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.30
自引率
0.00%
发文量
54
审稿时长
7 weeks
期刊介绍: Therapeutic Advances in Hematology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of hematology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in hematology, providing a forum in print and online for publishing the highest quality articles in this area.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信